We are live on
!
Find out more
CF
Corebridge Financial Portfolio holdings
AUM
$4.25M
1-Year Est. Return
33.15%
This Fund
S&P 500
This Quarter
Est. Return
+4.01%
1 Year Est. Return
-33.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$18.2B
AUM Growth
–
Cap. Flow
+$17.7B
Cap. Flow
% of AUM
97.06%
Top 10 Holdings %
Top 10 Hldgs %
26.4%
Holding
3,057
New
3,055
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$936M |
| 2 |
Apple
AAPL
|
+$762M |
| 3 |
NVIDIA
NVDA
|
+$739M |
| 4 |
Amazon
AMZN
|
+$480M |
| 5 |
Meta Platforms (Facebook)
META
|
+$317M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.31% |
| 2 | Financials | 12.14% |
| 3 | Healthcare | 11.33% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 10.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RPC
2226
Ridgepost Capital
RPC
$894M
| $190K | ﹤0.01% |
+22,394
| New | +$179K |
|
2227
Entrada Therapeutics
TRDA
$265M
| $189K | ﹤0.01% |
+13,284
| New | +$189K |
|
2228
NRC Health Common Stock
NRC
$467M
| $189K | ﹤0.01% |
+8,245
| New | +$254K |
|
2229
SIGA Technologies
SIGA
$218M
| $189K | ﹤0.01% |
+24,916
| New | +$203K |
|
2230
Phathom Pharmaceuticals
PHAT
$676M
| $189K | ﹤0.01% |
+18,358
| New | +$189K |
|
2231
Shore Bancshares
SHBI
$782M
| $189K | ﹤0.01% |
+16,494
| New | +$179K |
|
2232
Methode Electronics
MEI
$522M
| $189K | ﹤0.01% |
+18,245
| New | +$210K |
|
2233
Groupon
GRPN
$762M
| $189K | ﹤0.01% |
+12,324
| New | +$165K |
|
2234
Aura Biosciences
AURA
$726M
| $189K | ﹤0.01% |
+24,952
| New | +$183K |
|
2235
Alerus Financial
ALRS
$829M
| $188K | ﹤0.01% |
+9,595
| New | +$189K |
|
2236
The RMR Group
RMR
$325M
| $188K | ﹤0.01% |
+8,318
| New | +$195K |
|
2237
Advance Auto Parts
AAP
$2.7B
| $188K | ﹤0.01% |
+2,964
| New | +$212K |
|
2238
Rayonier Advanced Materials
RYAM
$575M
| $187K | ﹤0.01% |
+34,442
| New | +$168K |
|
2239
Rush Enterprises Class B
RUSHB
$5.82B
| $187K | ﹤0.01% |
+7,140
| New | +$206K |
|
|
VERV
2240
DELISTED
Verve Therapeutics
VERV
| $187K | ﹤0.01% |
+38,220
| New | +$240K |
|
2241
Westrock Coffee
WEST
$752M
| $186K | ﹤0.01% |
+18,228
| New | +$187K |
|
2242
OmniAb
OABI
$592M
| $186K | ﹤0.01% |
+49,650
| New | +$226K |
|
2243
Carter Bankshares
CARE
$723M
| $186K | ﹤0.01% |
+12,271
| New | +$154K |
|
2244
Advantage Solutions
ADV
$427M
| $185K | ﹤0.01% |
+2,303
| New | +$214K |
|
2245
Limoneira
LMNR
$236M
| $185K | ﹤0.01% |
+8,905
| New | +$179K |
|
|
FFWM
2246
DELISTED
First Foundation Inc
FFWM
| $184K | ﹤0.01% |
+28,149
| New | +$172K |
|
2247
Elastic
ESTC
$8.76B
| $184K | ﹤0.01% |
+1,618
| New | +$170K |
|
2248
Lindblad Expeditions
LIND
$1.68B
| $184K | ﹤0.01% |
+19,069
| New | +$148K |
|
2249
Strategy Inc
MSTR
$52B
| $183K | ﹤0.01% |
+1,330
| New | +$192K |
|
|
AGEN
2250
Agenus
AGEN
$312M
| $183K | ﹤0.01% |
+10,926
| New | +$132K |
|
Similar funds
WH
PS
CGA
EAMS
OFC
FM
BP
GFM
Corebridge Financial's Q2 2024 Portfolio in Review
Q2 2024 is the first quarter with a 13F filing on record for Corebridge Financial, which disclosed 3,057 positions worth $18.2B. Its ten largest holdings account for 26% of the portfolio.
Its largest position is Microsoft: 2,215,349 shares worth $990M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, followed by Financials and Healthcare.
- Corebridge Financial's largest Q2 2024 buy was Microsoft: 2,215,349 shares worth $990M.
- Corebridge Financial's ten largest holdings make up 26% of its $18.2B portfolio in Q2 2024.
- Corebridge Financial disclosed 3,057 positions in Q2 2024, its first 13F filing on record.
Based on Corebridge Financial's 13F filing for Q2 2024, filed 14 Aug 2024.